BBGBloomberg·10hBusiness
score+0.70
Odyssey Therapeutics Climbs 11% After $304 Million US IPO
Original
Odyssey Therapeutics Climbs 11% After $304 Million US IPO
“Celebratory language ('climbs,' 'jumped') emphasizes successful fundraising and market confidence in the company's debut.”